Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With Bronchiectasis

Chronic airways infection with Pseudomonas aeruginosa (PA) is associated with increased frequency of exacerbations, deterioration in quality of life and increased mortality in adult patients with bronchiectasis. Current guidelines suggest the prescription of an eradication antibiotic treatment for a first episode of PA infection (early PA infection). Several antibiotic regimens may be proposed, ranging from a monotherapy with oral fluoroquinolone (FQ) to an intravenous cotherapy with the addition of inhaled antibiotics that seems to improve the rate of PA eradication. As no study strictly favoured one regimen, current practices are heterogeneous and could certainly benefit from stronger evidence, with both medical and economic impact.

NCT Number	NCT06368804
Lead Sponsor	Centre Hospitalier Intercommunal Creteil Collaborators: Assistance Publique - Hôpitaux de Paris
Conditions	Bronchiectasis
Enrollment	196 participants
Start Date	2024-09-15
Primary Completion	2025-03-15 (estimated)
Study Completion	2028-09-15 (estimated)
Updated on ClinicalTrials.gov	2025-07-17